EXTENSION OF AN ARTIFICIAL CHROMOSOME-BASED SYSTEM AS A NOVEL DELIVERY STRATEGY FOR CAR-T CELL THERAPY OF OVARIAN CANCER TO HUMAN LYMPHOCYTES
$100,330FY2025Defense Health AgencyDOD
The General Hospital Corporation
Investigators
View source on USAspending →EXTENSION OF AN ARTIFICIAL CHROMOSOME-BASED SYSTEM AS A NOVEL DELIVERY STRATEGY FOR CAR-T CELL THERAPY OF OVARIAN CANCER TO HUMAN LYMPHOCYTES · GrantIndex